We are Sorry, This Page doesn't Exist

Flex Pharma (FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company also plans to lower its workforce by about 60%. F.....»»

Acceleron Pharma Inc (NASDAQ: XLRN), a clinical-stage biopharmaceutical focused on the treatment of serious and rare diseases, saw its stock soar after reporting encouraging Phase 3 data. Lates.....»»

Eyenovia (EYEN) starts enrollment in the first phase III study of a two clinical study program to evaluate its mydriasis candidate, MicroStat. Stock rallies. .....»»

The developer said the shift in interest rates and costs has provided a different look to housing developments......»»

Microsoft's stock rose 54% throughout 2023, boosting investor confidence in its growth potential. For long-term investors, if Microsoft's stock price goes above the $430 resistance level, it would signal a new phase of growth. read more.....»»

Sales of partially battery-powered vehicles, once ridiculed as a "phase" by the likes of Elon Musk, are rocketing even as EVs stutter. Toyota has reaped the benefi.....»»

After reaching a final investment decision for the first phase of Rio Grande LNG last year, NextDecade is already eyeing the next segment......»»

Price increases have been a challenge, according to the realtor for the development......»»

Phase 1 construction — featuring an eight-story, 350,000 square-foot building — is set to wrap by the end of 2026......»»

What"s in the three-phase ceasefire deal Hamas backs, but Israel does not?.....»»

EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile. read more.....»»

Technical chart analyst Ali Martinez points out Cardano (CRYPTO: ADA) may be set for an impressive bull run like in 2019. read more.....»»

Preliminary results of AEON Biopharma's Phase 2 trial .....»»

Work has already begun on Phase 1— renovating the former Basham's at 103 E. 21st St. into a commercial incubation kitchen, multi-purpose classroom and office space. Now, Empower is on a mission to raise the needed funds to get Phase 2 started......»»

NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression. read more.....»»

SPP executives shed light on the strategy behind Water Street's second phase......»»

Latest Phase 2 epilepsy study findings on ADX71149 adjunctive therapy for focal onset seizures. Partnered with Janssen, Addex Therapeutics evaluates treatment efficacy in patients with suboptimal response to standard care. read more.....»»

– 2023 marked by Ceapro's achievement of key milestones and progress toward its next phase of growth – R&D activities focuse.....»»

The contract is for the first phase of an estimated $90 million in cargo infrastructure expansion and improvement work, the Port of Galveston's first major cargo infrastructure improvement project in decades......»»

Sustainability is the name of the game at Innovation Campus and its newest office development, Innovation One......»»